| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.33 | 0.002 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |